Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 310

1.

PTTG1: a Unique Regulator of Stem/Cancer Stem Cells in the Ovary and Ovarian Cancer.

Parte S, Virant-Klun I, Patankar M, Batra SK, Straughn A, Kakar SS.

Stem Cell Rev Rep. 2019 Sep 3. doi: 10.1007/s12015-019-09911-5. [Epub ahead of print]

PMID:
31482269
2.

Reproducibility of CRISPR-Cas9 methods for generation of conditional mouse alleles: a multi-center evaluation.

Gurumurthy CB, O'Brien AR, Quadros RM, Adams J Jr, Alcaide P, Ayabe S, Ballard J, Batra SK, Beauchamp MC, Becker KA, Bernas G, Brough D, Carrillo-Salinas F, Chan W, Chen H, Dawson R, DeMambro V, D'Hont J, Dibb KM, Eudy JD, Gan L, Gao J, Gonzales A, Guntur AR, Guo H, Harms DW, Harrington A, Hentges KE, Humphreys N, Imai S, Ishii H, Iwama M, Jonasch E, Karolak M, Keavney B, Khin NC, Konno M, Kotani Y, Kunihiro Y, Lakshmanan I, Larochelle C, Lawrence CB, Li L, Lindner V, Liu XD, Lopez-Castejon G, Loudon A, Lowe J, Jerome-Majewska LA, Matsusaka T, Miura H, Miyasaka Y, Morpurgo B, Motyl K, Nabeshima YI, Nakade K, Nakashiba T, Nakashima K, Obata Y, Ogiwara S, Ouellet M, Oxburgh L, Piltz S, Pinz I, Ponnusamy MP, Ray D, Redder RJ, Rosen CJ, Ross N, Ruhe MT, Ryzhova L, Salvador AM, Alam SS, Sedlacek R, Sharma K, Smith C, Staes K, Starrs L, Sugiyama F, Takahashi S, Tanaka T, Trafford AW, Uno Y, Vanhoutte L, Vanrockeghem F, Willis BJ, Wright CS, Yamauchi Y, Yi X, Yoshimi K, Zhang X, Zhang Y, Ohtsuka M, Das S, Garry DJ, Hochepied T, Thomas P, Parker-Thornburg J, Adamson AD, Yoshiki A, Schmouth JF, Golovko A, Thompson WR, Lloyd KCK, Wood JA, Cowan M, Mashimo T, Mizuno S, Zhu H, Kasparek P, Liaw L, Miano JM, Burgio G.

Genome Biol. 2019 Aug 26;20(1):171. doi: 10.1186/s13059-019-1776-2.

3.

Vitamin E δ-tocotrienol sensitizes human pancreatic cancer cells to TRAIL-induced apoptosis through proteasome-mediated down-regulation of c-FLIPs.

Francois RA, Zhang A, Husain K, Wang C, Hutchinson S, Kongnyuy M, Batra SK, Coppola D, Sebti SM, Malafa MP.

Cancer Cell Int. 2019 Jul 22;19:189. doi: 10.1186/s12935-019-0876-0. eCollection 2019.

4.

Comparative Study of Subcutaneous and Orthotopic Mouse Models of Prostate Cancer: Vascular Perfusion, Vasculature Density, Hypoxic Burden and BB2r-Targeting Efficacy.

Zhang W, Fan W, Rachagani S, Zhou Z, Lele SM, Batra SK, Garrison JC.

Sci Rep. 2019 Jul 31;9(1):11117. doi: 10.1038/s41598-019-47308-z.

5.

Small Cell Lung Cancer Therapeutic Responses Through Fractal Measurements: From Radiology to Mitochondrial Biology.

Mambetsariev I, Mirzapoiazova T, Lennon F, Jolly MK, Li H, Nasser MW, Vora L, Kulkarni P, Batra SK, Salgia R.

J Clin Med. 2019 Jul 16;8(7). pii: E1038. doi: 10.3390/jcm8071038.

6.

Amphiphilic polyanhydride-based recombinant MUC4β-nanovaccine activates dendritic cells.

Banerjee K, Gautam SK, Kshirsagar P, Ross KA, Spagnol G, Sorgen P, Wannemuehler MJ, Narasimhan B, Solheim JC, Kumar S, Batra SK, Jain M.

Genes Cancer. 2019 May;10(3-4):52-62. doi: 10.18632/genesandcancer.189.

7.

Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells.

Vengoji R, Macha MA, Nimmakayala RK, Rachagani S, Siddiqui JA, Mallya K, Gorantla S, Jain M, Ponnusamy MP, Batra SK, Shonka N.

J Exp Clin Cancer Res. 2019 Jun 18;38(1):266. doi: 10.1186/s13046-019-1264-2.

8.

Anti-Claudin-1 Conjugated to a Near-Infrared Fluorophore Targets Colon Cancer in PDOX Mouse Models.

Hollandsworth HM, Lwin TM, Amirfakhri S, Filemoni F, Batra SK, Hoffman RM, Dhawan P, Bouvet M.

J Surg Res. 2019 Oct;242:145-150. doi: 10.1016/j.jss.2019.04.048. Epub 2019 May 9.

PMID:
31077946
9.

Trefoil factor(s) and CA19.9: A promising panel for early detection of pancreatic cancer.

Jahan R, Ganguly K, Smith LM, Atri P, Carmicheal J, Sheinin Y, Rachagani S, Natarajan G, Brand RE, Macha MA, Grandgenett PM, Kaur S, Batra SK.

EBioMedicine. 2019 Apr;42:375-385. doi: 10.1016/j.ebiom.2019.03.056. Epub 2019 Apr 5.

10.

FDPS cooperates with PTEN loss to promote prostate cancer progression through modulation of small GTPases/AKT axis.

Seshacharyulu P, Rachagani S, Muniyan S, Siddiqui JA, Cruz E, Sharma S, Krishnan R, Killips BJ, Sheinin Y, Lele SM, Smith LM, Talmon GA, Ponnusamy MP, Datta K, Batra SK.

Oncogene. 2019 Jun;38(26):5265-5280. doi: 10.1038/s41388-019-0791-9. Epub 2019 Mar 26.

PMID:
30914801
11.

Utilizing cell line-derived organoids to evaluate the efficacy of a novel LIFR-inhibitor, EC359 in targeting pancreatic tumor stroma.

Hall BR, Cannon A, Thompson C, Santhamma B, Chavez-Riveros A, Bhatia R, Nair HB, Nickisch K, Batra SK, Kumar S.

Genes Cancer. 2019 Feb;10(1-2):1-10. doi: 10.18632/genesandcancer.184.

12.

Combination Therapies and Drug Delivery Platforms in Combating Pancreatic Cancer.

Lei F, Xi X, Batra SK, Bronich TK.

J Pharmacol Exp Ther. 2019 Sep;370(3):682-694. doi: 10.1124/jpet.118.255786. Epub 2019 Feb 22.

PMID:
30796131
13.

Systems Biology Approach to Identify Novel Genomic Determinants for Pancreatic Cancer Pathogenesis.

Khatri I, Ganguly K, Sharma S, Carmicheal J, Kaur S, Batra SK, Bhasin MK.

Sci Rep. 2019 Jan 15;9(1):123. doi: 10.1038/s41598-018-36328-w.

14.

Cancer-associated mucins: role in immune modulation and metastasis.

Bhatia R, Gautam SK, Cannon A, Thompson C, Hall BR, Aithal A, Banerjee K, Jain M, Solheim JC, Kumar S, Batra SK.

Cancer Metastasis Rev. 2019 Jun;38(1-2):223-236. doi: 10.1007/s10555-018-09775-0. Review.

PMID:
30618016
15.

Immunometabolic Alterations by HPV Infection: New Dimensions to Head and Neck Cancer Disparity.

Chaudhary S, Ganguly K, Muniyan S, Pothuraju R, Sayed Z, Jones DT, Batra SK, Macha MA.

J Natl Cancer Inst. 2019 Mar 1;111(3):233-244. doi: 10.1093/jnci/djy207.

PMID:
30615137
16.

Dual delivery nanoscale device for miR-345 and gemcitabine co-delivery to treat pancreatic cancer.

Uz M, Kalaga M, Pothuraju R, Ju J, Junker WM, Batra SK, Mallapragada S, Rachagani S.

J Control Release. 2019 Jan 28;294:237-246. doi: 10.1016/j.jconrel.2018.12.031. Epub 2018 Dec 18.

PMID:
30576747
17.

Pancreatic cancer associated with obesity and diabetes: an alternative approach for its targeting.

Pothuraju R, Rachagani S, Junker WM, Chaudhary S, Saraswathi V, Kaur S, Batra SK.

J Exp Clin Cancer Res. 2018 Dec 19;37(1):319. doi: 10.1186/s13046-018-0963-4. Review.

18.

Label-free characterization of exosome via surface enhanced Raman spectroscopy for the early detection of pancreatic cancer.

Carmicheal J, Hayashi C, Huang X, Liu L, Lu Y, Krasnoslobodtsev A, Lushnikov A, Kshirsagar PG, Patel A, Jain M, Lyubchenko YL, Lu Y, Batra SK, Kaur S.

Nanomedicine. 2019 Feb;16:88-96. doi: 10.1016/j.nano.2018.11.008. Epub 2018 Dec 11.

PMID:
30550805
19.

Novel therapies hijack the blood-brain barrier to eradicate glioblastoma cancer stem cells.

Vengoji R, Ponnusamy MP, Rachagani S, Mahapatra S, Batra SK, Shonka N, Macha MA.

Carcinogenesis. 2019 Mar 12;40(1):2-14. doi: 10.1093/carcin/bgy171.

PMID:
30475990
20.

Novel role of O-glycosyltransferases GALNT3 and B3GNT3 in the self-renewal of pancreatic cancer stem cells.

Barkeer S, Chugh S, Karmakar S, Kaushik G, Rauth S, Rachagani S, Batra SK, Ponnusamy MP.

BMC Cancer. 2018 Nov 22;18(1):1157. doi: 10.1186/s12885-018-5074-2.

Supplemental Content

Loading ...
Support Center